• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Joint ECDC-WHO Regional Office for Europe Monkeypox Surveillance Bulletin (June 22, 2022)

Pathfinder

Editor, Senior Moderator
Joint ECDC - WHO Regional Office for Europe Monkeypox Surveillance Bulletin
P+20UYOTa+CsQAAAABJRU5ErkJggg==


Produced on 22 June 2022, 12:00


ECDC Situation risk assessment

WHO EURO Monkeypox webpage

Surveillance summary


A total of 2746 cases of monkeypox have been identified through IHR/EWRS mechanisms up to 21 June 2022, 14:00, from 29 countries and areas throughout the European region. Case-based data were reported for 1799 cases from 20 countries and areas to ECDC and the WHO Regional Office for Europe through The European Surveillance System (TESSy), up to 21 June 2022, 10:00.

Of the 1799 cases reported in TESSy, 1796 were laboratory confirmed. 21 were confirmed to be of the West African clade. The earliest date of symptom onset was reported as 08 April 2022. The majority of cases were between 31 and 40 years-old (792/1796 - 44.1%) and male (1761/1771 - 99.4%). Among cases with known HIV status, 115/281 - 40.9% were HIV-positive. No cases were reported to have died. So far 5 health care workers were notified as cases in TESSy. None are known to have acquired infection through occupational exposure to date.
INTRODUCTION
This report provides an overview of the total number of cases of monkeypox identified by ECDC and the WHO Regional Office for Europe through IHR/EWRS mechanisms and case-based data through The European Surveillance System (TESSy) up to 21 May 2022.

The first summary table describes the number of cases identified through the different platforms. The following figures and tables describe national case-based data for surveillance of monkeypox reported in TESSy from all the countries and areas of the WHO European Region, including the 27 countries of the European Union (EU) and the additional three countries of the European Economic Area (EEA).

Case Report Form Data are submitted through the case-based record type MPX to The European Surveillance System (TESSy) database hosted at ECDC.

KEY INDICATORS
Summary of number of cases of monkeypox identified through IHR/EWRS mechanisms and reported to TESSy, European Region, 2022
Austria110
Belgium7575
Czechia66
Denmark108
Finland40
France247247
Georgia11
Germany4690
Gibraltar10
Greece33
Hungary77
Iceland33
Ireland2420
Israel90
Italy8585
Latvia22
Luxembourg11
Malta22
Netherlands950
Norway44
Poland77
Portugal3040
Romania44
Serbia10
Slovenia77
Spain518520
Sweden1313
Switzerland400
United Kingdom793784
Total27461799


...


https://monkeypoxreport.ecdc.europa.eu/
 
Back
Top